Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

Across the Pharma and Life Sciences landscape, a new rhythm of innovation and resilience is taking shape. The sector’s evolution is not defined solely by scientific milestones but by the steady alignment of leadership, investment, and advanced capability, the cornerstones of sustained progress. In Matt Moran brings three decades of biopharma leadership to the judging panel, experience meets foresight as one of Ireland’s most respected industry figures helps chart the future of excellence and collaboration. This emphasis on leadership complements the sector-wide momentum captured in UK life sciences gains momentum with Moderna investment, where strategic funding signals renewed confidence in research-driven growth. Meanwhile, SGS ISL expands capabilities with polarised light microscopy for asbestos testing reflects how precision science continues to strengthen quality assurance and public health outcomes. These developments illustrate a sector not merely adapting but advancing — guided by vision, underpinned by rigour, and committed to continuous improvement.

Author: Jed Nykolle Harme

Matt Moran, CEO of Matt Moran Consulting, joins the judging panel of the Pharma Industry Awards 2025 as Judging Coordinator, bringing more than 30 years of leadership in the biopharmaceutical sector.

Author: Caixin Global

China’s Zhongguancun Life Science Park in Beijing is transforming pharma innovation, hosting over 1,000 companies and R&D institutes. The hub advances cell and gene therapies, neuroscience, AI healthcare, and first-in-class drugs.

Author: Global Bio Defense

The UK bolsters its life sciences leadership with Moderna’s £1BN Innovation and Technology Centre in Harwell and a £50M public R&D fund, enhancing mRNA innovation, pandemic preparedness, and biomedical sector growth.

Author: Irish Tech News

Alexion, AstraZeneca Rare Disease has expanded in Cork, enhancing Ireland’s life sciences hub by boosting research, talent development, and supply chain operations to advance therapies for rare disease patients globally.

Author: Logistics Manager

DHL Supply Chain is investing £550 million to scale automation, robotics, and healthcare logistics across the UK and Ireland. The move strengthens supply chain resilience, supports high-growth industries, and aligns with the UK’s trade strategy.

Author: Irish Legal News

Mason Hayes & Curran has launched Capsule, new digital platform providing regulatory insights and sector-specific updates for life sciences companies. The resource supports compliance, risk management and growth in an increasingly complex EU and global market.

Author: Jed Nykolle Harme

To support our clients with changing pharmacopoeial requirements, SGS ISL is introducing Polarised Light Microscopy to complement our existing XRPD for the introduction of raw material Asbestos testing in December 2025.

Author: Jed Nykolle Harme

Pharmaceutical companies are facing mounting challenges in meeting regulatory demands, accelerating product development and overcoming workforce shortages. To address these pressures, SGS is expanding its agile insourcing programme, embedding skilled scientific staff directly within client facilities.

Author: Jed Nykolle Harme

The Pharma Industry Awards 2025 has unveiled its shortlist, marking a pivotal moment in Ireland’s pharmaceutical calendar. Now in its 12th year, the programme stands as the country’s most prestigious celebration of excellence, innovation, and leadership across the life sciences.